Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 12, Pages 3529
Publisher
MDPI AG
Online
2020-11-27
DOI
10.3390/cancers12123529
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer
- (2020) Jessica C. Casciano et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
- (2020) Wenting Zhang et al. Frontiers in Immunology
- Microsatellite instability and mismatch repair protein expressions in lymphocyte‐predominant breast cancer
- (2020) Yoshiya Horimoto et al. CANCER SCIENCE
- High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
- (2020) Ping Mei et al. Diagnostic Pathology
- Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA.
- (2020) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment
- (2020) Tao Shi et al. Frontiers in Immunology
- Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
- (2020) Wenjie Yang et al. Annals of Translational Medicine
- Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors
- (2020) Noelia Vilariño et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
- (2020) Omid Kooshkaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lipid composition of the cancer cell membrane
- (2020) Wojciech Szlasa et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation
- (2020) Zhi-Ling Li et al. Nature Communications
- Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites
- (2020) Claudie Bosc et al. Nature Communications
- LBA15 Primary results from IMpassion131, a double-blind placebo-controlled randomised phase III trial of first-line paclitaxel (PAC) ± atezolizumab (atezo) for unresectable locally advanced/metastatic triple-negative breast cancer (mTNBC)
- (2020) D.W. Miles et al. ANNALS OF ONCOLOGY
- USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer
- (2020) Teng Ma et al. BMC CANCER
- A miR-210-3p regulon that controls the Warburg effect by modulating HIF-1α and p53 activity in triple-negative breast cancer
- (2020) Ye Du et al. Cell Death & Disease
- CD73 expression in normal and pathological human hepatobiliopancreatic tissues
- (2019) Amedeo Sciarra et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers
- (2019) Yanjun Hou et al. HUMAN PATHOLOGY
- Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016
- (2019) Rajesh Sharma Breast Cancer
- PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review
- (2019) Aurora Mirabile et al. Cancers
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma
- (2019) Dimitra Kerdidani et al. Nature Communications
- WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
- (2019) Lorenzo Castagnoli et al. ONCOGENE
- Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
- (2019) Jun Wang et al. NATURE MEDICINE
- LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195
- (2019) Qing-Ming Wang et al. LIFE SCIENCES
- A randomized phase Ib/II study of nivolumab with or without BMS-986253 in combination with a short course of ADT in men with castration-sensitive prostate cancer (MAGIC-8).
- (2019) Matthew Dallos et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- A Novel Specific Anti-CD73 Antibody Inhibits Triple-Negative Breast Cancer Cell Motility by Regulating Autophagy
- (2019) Zheng Qiao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- 195TiPSYNERGY: Phase I and randomized phase II trial to investigate the addition of the anti-CD73 antibody oleclumab to durvalumab, paclitaxel and carboplatin for previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)
- (2019) C Maurer et al. ANNALS OF ONCOLOGY
- Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
- (2019) Yuan Cheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
- (2019) Xingzhe Ma et al. Cell Metabolism
- Repression of lncRNA NEAT1 enhances the antitumor activity of CD8+T cells against hepatocellular carcinoma via regulating miR-155/Tim-3
- (2019) Kai Yan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Autophagy-related 7 modulates tumor progression in triple-negative breast cancer
- (2019) Mingyang Li et al. LABORATORY INVESTIGATION
- Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
- (2019) Xiao Wei et al. Translational Oncology
- Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets
- (2019) Sasha E. Stanton et al. VACCINE
- HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
- (2019) Jason Miska et al. Cell Reports
- Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy
- (2019) Yan Zhang et al. CELL RESEARCH
- Recent Advances of Small Molecular Regulators Targeting G Protein-Coupled Receptors Family for Oncology Immunotherapy
- (2019) Peng He et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The lncRNA UCA1 promotes proliferation, migration, immune escape and inhibits apoptosis in gastric cancer by sponging anti-tumor miRNAs
- (2019) Chao-Jie Wang et al. Molecular Cancer
- High expression of soluble CD155 in estrogen receptor-negative breast cancer
- (2019) Akiko Iguchi-Manaka et al. Breast Cancer
- High expression of CD47 in triple negative breast cancer is associated with epithelial‑mesenchymal transition and poor prognosis
- (2019) Jingping Yuan et al. Oncology Letters
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- Increased Cholesterol Biosynthesis Is a Key Characteristic of Breast Cancer Stem Cells Influencing Patient Outcome
- (2019) Sidse Ehmsen et al. Cell Reports
- CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth
- (2019) Ru Zhou et al. Frontiers in Immunology
- Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity
- (2019) Felix L. Fennemann et al. Frontiers in Immunology
- Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells
- (2019) Sujin Lee et al. Redox Biology
- DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
- (2019) Beatriz Sanchez-Correa et al. Cancers
- Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
- (2019) Jeonghun Han et al. Journal of Oncology
- Transformable Nanoparticle‐Enabled Synergistic Elicitation and Promotion of Immunogenic Cell Death for Triple‐Negative Breast Cancer Immunotherapy
- (2019) Chenfeng Xu et al. ADVANCED FUNCTIONAL MATERIALS
- Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
- (2019) Marijo Bilusic et al. Journal for ImmunoTherapy of Cancer
- LBA78IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1–selected NSCLC
- (2019) D Spigel et al. ANNALS OF ONCOLOGY
- LBA21KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)
- (2019) J Cortés et al. ANNALS OF ONCOLOGY
- Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
- (2019) Robert D. Leone et al. SCIENCE
- Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization
- (2019) Marta Pérez-Hernández et al. Cancers
- CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
- (2019) Shujun Han et al. Frontiers in Oncology
- The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism
- (2019) Karolien Vanhove et al. Frontiers in Oncology
- Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
- (2019) Saleh et al. Vaccines
- Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy
- (2019) Yang Liu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Checkpoint inhibitors in triple-negative breast cancer (TNBC): Where to go from here
- (2018) Maryann J. Kwa et al. CANCER
- Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis
- (2018) Anna Halama et al. CANCER LETTERS
- High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis
- (2018) Daniele Avanzato et al. CANCER RESEARCH
- Combination Therapy and the Evolution of Resistance: The Theoretical Merits of Synergism and Antagonism in Cancer
- (2018) Elysia C. Saputra et al. CANCER RESEARCH
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine
- (2018) Yee Sun Tan et al. CLINICAL CANCER RESEARCH
- Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers
- (2018) Ashwini Raghavendra et al. HISTOPATHOLOGY
- Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
- (2018) Xichen Zheng et al. JOURNAL OF CLINICAL INVESTIGATION
- Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells
- (2018) Yali Han et al. Journal of Hematology & Oncology
- Neurologic complications of immune checkpoint inhibitors
- (2018) Avi Fellner et al. JOURNAL OF NEURO-ONCOLOGY
- Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states
- (2018) Andrew Sulaiman et al. Molecular Oncology
- Cancer/testis antigen-Plac1 promotes invasion and metastasis of breast cancer through Furin/NICD/PTEN signaling pathway
- (2018) Yongfei Li et al. Molecular Oncology
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Wnt/β-Catenin Signaling for Cancer Immunotherapy
- (2018) Bojun Wang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
- (2018) Xuhao Ni et al. Cancer Discovery
- Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
- (2018) Santosh K. Bharti et al. Oncotarget
- Exploring the links between cancer and placenta development
- (2018) Vincenzo Costanzo et al. Open Biology
- YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
- (2018) Min Hwan Kim et al. Cancer Immunology Research
- Unveiling the Role of Ecto-5′-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools
- (2018) Marija Adzic et al. Frontiers in Pharmacology
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis
- (2018) Heidi Harjunpää et al. OncoImmunology
- Prevalence of PDL1 Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors
- (2018) Aaron M. Goodman et al. JAMA Oncology
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- TIGIT: a novel immunotherapy target moving from bench to bedside
- (2018) Benjamin L. Solomon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Abstract CT180: Preliminary phase 1 profile of BMS-986179, an anti-CD73 antibody, in combination with nivolumab in patients with advanced solid tumors
- (2018) Lillian L. Siu et al. CANCER RESEARCH
- Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast Cancer
- (2018) Alma Campos-Parra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011 +/- nivolumab (nivo) in patients (pts) with advanced cancers.
- (2018) Timothy Anthony Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Rheumatic immune-related adverse events from cancer immunotherapy
- (2018) Leonard H. Calabrese et al. Nature Reviews Rheumatology
- Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells
- (2018) Sangmin Kim et al. PHYTOMEDICINE
- Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
- (2018) Jie Lan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer
- (2018) Sandra L. Romero-Cordoba et al. Scientific Reports
- Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials
- (2018) Jonathan G. Pol et al. OncoImmunology
- Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer
- (2018) Leisha A. Emens et al. JAMA Oncology
- Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer
- (2018) Sangiliyandi Gurunathan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Unravelling the Interplay between Extracellular Acidosis and Immune Cells
- (2018) Fernando Erra Díaz et al. MEDIATORS OF INFLAMMATION
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
- (2018) Rodabe N. Amaria et al. NATURE MEDICINE
- Physical activation of innate immunity by spiky particles
- (2018) Ji Wang et al. Nature Nanotechnology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential clinical application of lncRNAs in non-small cell lung cancer
- (2018) Tong Lu et al. OncoTargets and Therapy
- CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer
- (2018) Shenglan Gu et al. Journal of Immunology Research
- The clinical promise of immunotherapy in triple-negative breast cancer
- (2018) Praveen Vikas et al. Cancer Management and Research
- Immunological therapy: A novel thriving area for triple-negative breast cancer treatment
- (2018) Xiangyu Wang et al. CANCER LETTERS
- Dendritic cell-based immunotherapy: a basic review and recent advances
- (2017) João Constantino et al. IMMUNOLOGIC RESEARCH
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- LncRNAs: From Basic Research to Medical Application
- (2017) Tao Wu et al. International Journal of Biological Sciences
- Combining Nanoparticle-Aided Radiation Therapy with Immunotherapy to Enhance Local and Metastatic Tumor Cell Kill During Pancreatic Cancer Treatment
- (2017) W. Ngwa et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
- (2017) Xiaojia Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Is CD47 an innate immune checkpoint for tumor evasion?
- (2017) Xiaojuan Liu et al. Journal of Hematology & Oncology
- Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism
- (2017) Tao Xu et al. NATURE
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
- (2017) Lin Tian et al. NATURE
- Tumour ischaemia by interferon-γ resembles physiological blood vessel regression
- (2017) Thomas Kammertoens et al. NATURE
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
- (2017) Jeffrey Weber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells
- (2017) J Feng et al. ONCOGENE
- Localized CD47 blockade enhances immunotherapy for murine melanoma
- (2017) Jessica R. Ingram et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Combined immune checkpoint blockade as a therapeutic strategy for BRCA1 -mutated breast cancer
- (2017) Emma Nolan et al. Science Translational Medicine
- Deciphering metabolic rewiring in breast cancer subtypes
- (2017) Martin P. Ogrodzinski et al. Translational Research
- A molecular portrait of microsatellite instability across multiple cancers
- (2017) Isidro Cortes-Ciriano et al. Nature Communications
- Roles of MALAT1 in development and migration of triple negative and Her-2 positive breast cancer
- (2017) Zhang Xiping et al. Oncotarget
- Clinicopathological and prognostic significance of c-Met overexpression in breast cancer
- (2017) Xixi Zhao et al. Oncotarget
- The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer
- (2017) Hitomi Mori et al. Oncotarget
- YAP regulates PD-L1 expression in human NSCLC cells
- (2017) Jinbai Miao et al. Oncotarget
- Impact of Statin Use on Outcomes in Triple Negative Breast Cancer
- (2017) Simona F. Shaitelman et al. Journal of Cancer
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
- (2017) Julia Tchou et al. Cancer Immunology Research
- Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
- (2017) Casey R. Ager et al. Cancer Immunology Research
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Cholesterol Metabolism in T Cells
- (2017) Andreas Bietz et al. Frontiers in Immunology
- Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition
- (2017) Michael Lampa et al. PLoS One
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- MxA expression is associated with tumor-infiltrating lymphocytes and is a prognostic factor in triple-negative breast cancer
- (2016) Young-Ae Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- The Role of Cholesterol in Cancer
- (2016) Omer F. Kuzu et al. CANCER RESEARCH
- The CXCL8-CXCR1/2 pathways in cancer
- (2016) Qian Liu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2016) Johan F Vansteenkiste et al. LANCET ONCOLOGY
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
- (2016) Roman Camarda et al. NATURE MEDICINE
- Aurora A kinase activates YAP signaling in triple-negative breast cancer
- (2016) S-S Chang et al. ONCOGENE
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
- (2016) Chunbai He et al. Nature Communications
- A function-blocking CD47 antibody suppresses stem cell and EGF signaling in triple-negative breast cancer
- (2016) Sukhbir Kaur et al. Oncotarget
- Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
- (2016) Jun Hyoung Park et al. Cell Reports
- Angiopoietin-2 as a Biomarker and Target for Immune Checkpoint Therapy
- (2016) Xinqi Wu et al. Cancer Immunology Research
- The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
- (2016) Kankana Bardhan et al. Frontiers in Immunology
- Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors
- (2016) Claire F. Friedman et al. JAMA Oncology
- PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes
- (2015) H. R. Ali et al. ANNALS OF ONCOLOGY
- Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
- (2015) Jian Wen et al. BREAST CANCER RESEARCH AND TREATMENT
- The Contribution of Angiogenesis to the Process of Metastasis
- (2015) Diane R. Bielenberg et al. CANCER JOURNAL
- PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
- (2015) Fanny Dupuy et al. Cell Metabolism
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
- (2015) M van Geldermalsen et al. ONCOGENE
- HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
- (2015) Huimin Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
- (2015) Liangliang Shen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Antagonists of PD-1 and PD-L1 in Cancer Treatment
- (2015) Evan J. Lipson et al. SEMINARS IN ONCOLOGY
- Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus
- (2015) Sébastien A. Felt et al. VIROLOGY
- Interleukin-8: A potent promoter of angiogenesis in gastric cancer
- (2015) JUN SHI et al. Oncology Letters
- Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
- (2015) G. Wang et al. Cancer Discovery
- Prognostic and predictive value of PDL1 expression in breast cancer
- (2015) Renaud Sabatier et al. Oncotarget
- Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer
- (2015) Michael T. Barrett et al. Oncotarget
- Nanoparticles for Radiation Therapy Enhancement: the Key Parameters
- (2015) Paul Retif et al. Theranostics
- Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
- (2015) Agnieszka Zimna et al. Biomed Research International
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
- (2014) Luca Azzolin et al. CELL
- The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer Cells
- (2014) Samantha E. Hiemer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics
- (2014) A. G. Jarnicki et al. JOURNAL OF IMMUNOLOGY
- CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
- (2014) Masahide Takedachi et al. JOURNAL OF IMMUNOLOGY
- Complementary Induction of Immunogenic Cell Death by Oncolytic Parvovirus H-1PV and Gemcitabine in Pancreatic Cancer
- (2014) A. L. Angelova et al. JOURNAL OF VIROLOGY
- Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization
- (2014) Min Yang et al. Molecular Cancer
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Role of Angiopoietin-2 in Adaptive Tumor Resistance to VEGF Signaling Blockade
- (2014) Nicolò Rigamonti et al. Cell Reports
- Antigen-specific vaccines for cancer treatment
- (2014) Maria Tagliamonte et al. Human Vaccines & Immunotherapeutics
- Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
- (2014) B. Schrand et al. Cancer Immunology Research
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
- (2013) Yan Ni Loh et al. BMC CANCER
- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Long Noncoding RNAs: Past, Present, and Future
- (2013) J. T. Y. Kung et al. GENETICS
- Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model
- (2013) Aniruddha Roy et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
- (2013) J. Yu et al. JOURNAL OF IMMUNOLOGY
- Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
- (2013) Birdal Bilir et al. Journal of Translational Medicine
- High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancer
- (2013) Hong Zhao et al. MEDICAL ONCOLOGY
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Paracrine Wnt signaling both promotes and inhibits human breast tumor growth
- (2013) J. L. Green et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene
- (2013) R. Yamada et al. TISSUE ANTIGENS
- Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition
- (2012) Ulf D. Kahlert et al. CANCER LETTERS
- Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity
- (2012) N. Ning et al. CANCER RESEARCH
- Metabolism-Related Proteins Are Differentially Expressed according to the Molecular Subtype of Invasive Breast Cancer Defined by Surrogate Immunohistochemistry
- (2012) Junjeong Choi et al. PATHOBIOLOGY
- Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
- (2012) Foluso O. Ademuyiwa et al. PLoS One
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting pattern recognition receptors in cancer immunotherapy
- (2012) Nadège Goutagny et al. Targeted Oncology
- Chemotherapy-Induced Neuropathic Pain and Its Relation to Cluster Symptoms in Breast Cancer Patients Treated with Paclitaxel
- (2012) Yael Golan-Vered et al. Pain Practice
- The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
- (2012) Matteo Bellone et al. OncoImmunology
- IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells
- (2011) R. I. Fernando et al. CANCER RESEARCH
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- Virus-induced tumor inflammation facilitates effective DC cancer immunotherapy in a Treg-dependent manner in mice
- (2011) Norman Woller et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
- (2011) Barbara Molon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
- (2011) S. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy
- (2011) Jeanette E Boudreau et al. MOLECULAR THERAPY
- BRCA1 tumour suppression occurs via heterochromatin-mediated silencing
- (2011) Quan Zhu et al. NATURE
- Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment
- (2010) Pei Wang et al. CANCER LETTERS
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- PD-L1 expression on tolerogenic APCs is controlled by STAT-3
- (2010) Sabine J. Wölfle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- -Catenin Inhibits T Cell Activation by Selective Interference with Linker for Activation of T Cells-Phospholipase C- 1 Phosphorylation
- (2010) G. Driessens et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
- (2009) M. K. Srivastava et al. CANCER RESEARCH
- PD-1 Is a Regulator of NY-ESO-1-Specific CD8+ T Cell Expansion in Melanoma Patients
- (2009) J. Fourcade et al. JOURNAL OF IMMUNOLOGY
- Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence
- (2008) Juan C. Acosta et al. CELL
- The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression
- (2008) Elizabeth Vincan et al. CLINICAL & EXPERIMENTAL METASTASIS
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
- (2008) Silvia Piconese et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chemotherapy and tumor immunity: an unexpected collaboration
- (2007) Leisha et al. Frontiers in Bioscience-Landmark
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started